Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Curr Pharm Des ; 20(2): 253-61, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-23701541

RESUMEN

4ß-cinnamoyloxy,1ß,3α-dihydroxyeudesm-7,8-ene (CDE) extracted from Verbesina persicifolia induces bioenergetic collapse in rat liver mitochondria (RLM), monitored as a fall in the respiratory control index and ADP/O values. This fall in energy is accompanied by a protonophore effect and membrane potential (Δψ) collapse, demonstrating that CDE behaves as a typical uncoupling agent. However, when examining the effect of CDE in detail, we found that it acts as a "mild" uncoupler because it drops Δψ and increases respiratory state 4. The proposed mechanism is based on the interaction of CDE with membrane protein cytochrome C oxidase, which is implicated in proton permeability, and with the respiratory chain for the generation of reactive oxygen species which mediate and regulate the activity of the above membrane protein. Considering the energy collapse, "mild" uncoupling, and the fact that CDE is largely used in folk medicines, this extract may be viewed as a potentially effective anti-obesity drug and a natural lead compound for developing new natural uncouplers against obesity.


Asunto(s)
Fármacos Antiobesidad/farmacología , Mitocondrias Hepáticas/efectos de los fármacos , Sesquiterpenos de Eudesmano/farmacología , Verbesina/química , Animales , Fármacos Antiobesidad/aislamiento & purificación , Transporte de Electrón/efectos de los fármacos , Complejo IV de Transporte de Electrones/metabolismo , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Ratas , Especies Reactivas de Oxígeno/metabolismo , Sesquiterpenos de Eudesmano/aislamiento & purificación , Desacopladores/aislamiento & purificación , Desacopladores/farmacología
2.
Curr Pharm Des ; 20(2): 223-44, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-23701547

RESUMEN

Mitochondria are the cell powerhouses but also contain the mechanisms leading to cell death. Many signals converge on mitochondria to cause the permeabilization of mitochondrial membranes by the mitochondrial permeability transition (MPT) induction and the opening of transition pores (PTPs). These events cause loss of ionic homeostasis, matrix swelling, outer membrane rupture leading to pro-apoptotic factors release, and impairment of bioenergetics functions. The molecular mechanism underlying MPT induction is not completely elucidated however, a growing body of evidence supports the concept that pharmacological induction of PTPs in mitochondria of neoplastic cells is an effective and promising strategy for therapeutic approaches against cancer. The first part of this article presented as a review also evidences the main constituents of PTP and several compounds targeting them for inducing the phenomenon. The second part of the article regards the recent experimental development in the field, in particular, the effects of peniocerol (PEN), a sterol isolated from the root of Myrtillocactus geometrizans, at cellular and mitochondrial level. PEN exhibits a cytotoxic activity on some human tumor cell lines, whose mechanism is attributable to the oxidation of critical thiols located on adenine nucleotide translocase, the protein mainly involved in PTP. This event in the presence of Ca(2+) induces the MPT with the release of the pro-apoptotic factors cytochrome c and apoptosis inducing factor. These observations evidence that PEN may trigger both the caspase-dependent and caspaseindependent apoptotic pathways. This characteristic renders PEN a very interesting compound that could be developed to obtain more effective antiproliferative agents targeting mitochondria for anticancer therapy.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias/tratamiento farmacológico , Esteroles/farmacología , Animales , Apoptosis/efectos de los fármacos , Factor Inductor de la Apoptosis/metabolismo , Cactaceae/química , Caspasas/metabolismo , Humanos , Mitocondrias/metabolismo , Proteínas de Transporte de Membrana Mitocondrial/metabolismo , Membranas Mitocondriales/metabolismo , Poro de Transición de la Permeabilidad Mitocondrial , Terapia Molecular Dirigida , Neoplasias/metabolismo , Esteroles/aislamiento & purificación
3.
Bioorg Med Chem ; 21(22): 6965-72, 2013 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-24095013

RESUMEN

A convenient synthetic route and the characterization of complexes trans-[PtCl2(L)(PPh3)] (L=Et2NH (2), (PhCH2)2NH (3), (HOCH2CH2)2NH) (4) are reported. The antiproliferative activity was evaluated on three human tumor cell lines. The investigation on the mechanism of action highlighted for the most active complex 4 the capacity to affect mitochondrial functions. In particular, both the induction of the mitochondrial permeability transition phenomenon and an aspecific membrane damage occurred, depending on concentration.


Asunto(s)
Antineoplásicos/farmacología , Complejos de Coordinación/síntesis química , Mitocondrias/efectos de los fármacos , Platino (Metal)/química , Platino (Metal)/farmacología , Antineoplásicos/síntesis química , Antineoplásicos/química , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Complejos de Coordinación/química , Complejos de Coordinación/farmacología , Células HeLa , Humanos , Isomerismo , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Mitocondrias/metabolismo , Fosfinas/química
4.
Bioorg Med Chem ; 20(11): 3603-8, 2012 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-22537681

RESUMEN

The synthesis of 8,9,10,11-tetrahydro-5-(3-dimethylaminopropoxy)-4-methylbenzofuro[2,3-h]coumarin (5) is described. The new compound showed the ability to inhibit cell growth both upon UVA irradiation and in the dark. The investigation on the mechanism of action highlighted the capacity of 5 to covalently photoadd to thymine, as demonstrated by the isolation and characterization of the 4',5'-monoadduct. Furthermore, in the ground state 5 interferes with the topoisomerase II relaxation activity, suggesting that this enzyme could constitute a molecular target responsible for the dark antiproliferative effect.


Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Furocumarinas/síntesis química , Furocumarinas/farmacología , Antineoplásicos/química , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , ADN/química , Aductos de ADN , ADN-Topoisomerasas de Tipo II/metabolismo , Oscuridad , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Estructura Molecular , Fotoquimioterapia , Timina/química , Inhibidores de Topoisomerasa II/síntesis química , Inhibidores de Topoisomerasa II/química , Inhibidores de Topoisomerasa II/farmacología , Rayos Ultravioleta
5.
J Nat Prod ; 75(4): 557-62, 2012 Apr 27.
Artículo en Inglés | MEDLINE | ID: mdl-22458644

RESUMEN

Previous investigations on the biological effects of 3α-hydroxymasticadienonic acid (1) have demonstrated both anti-inflammatory and cytotoxic activities. However, neither the molecular mechanism of cytotoxic action nor the possible intracellular target(s) have been reported so far for this compound. The crucial role played by mitochondria on both cell survival and death, due to production of ATP and intrinsic apoptosis, respectively, prompted a study of the effect of 1 on isolated rat liver mitochondria. It was found that 1 causes a dose-dependent impairment of mitochondrial bioenergetic parameters, such as the respiratory control index and transmembrane electrical potential. Moreover, in the presence of Ca(2+), at a 10 µM concentration, 1 resulted in the induction of membrane permeability transition by oxidative stress, leading to the release of pro-apoptotic factors. At a 100 µM concentration, compound 1 affected mitochondrial Ca(2+) transport by inhibiting the accumulation of the cation in the mitochondrial matrix. Altogether, it was demonstrated that 1 induces an impairment of mitochondrial functions that may account for the cytotoxicity exhibited by this compound.


Asunto(s)
Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Triterpenos/aislamiento & purificación , Triterpenos/farmacología , Animales , Apoptosis/efectos de los fármacos , Calcio/análisis , Calcio/metabolismo , Células HeLa , Humanos , Hígado/citología , Hígado/efectos de los fármacos , Estructura Molecular , Estrés Oxidativo/efectos de los fármacos , Ratas , Triterpenos/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA